APOE4 dysregulates autophagy in cultured cells

• Published in: Autophagy reports Vol. 1; no. 1; pp. 29 - 33
• Main Authors: Fote, Gianna M, Steffan, Joan S
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis Group 01.01.2022
• Subjects: alzheimer’s disease; apoe; apoe4; chaperone-mediated autophagy; lamp2a; chaperone-mediated autophagy; APOE; Alzheimer’s disease; APOE4; LAMP2A
• ISSN: 2769-4127; 2769-4127
• DOI: 10.1080/27694127.2022.2040767

Human APOE4 (apolipoprotein E4 isoform) is a powerful genetic risk factor for late-onset Alzheimer disease (AD). Many groups have investigated the effect of APOE4 on the degradation of amyloid β (Aβ), the main component of plaques found in the brains of AD patients. However, few studies have focused on the degradation of APOE itself. We investigated the lysosomal trafficking of APOE in cells and found that APOE from the post-Golgi compartment is degraded through an autophagic process requiring the lysosomal membrane protein LAMP2A. We found that APOE4 accumulates in enlarged lysosomes, alters autophagic flux, and changes the proteomic contents of lysosomes following internalization. This dysregulated lysosomal trafficking may represent one of the mechanisms that contributes to AD pathogenesis.